These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21411156)

  • 1. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
    Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
    Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
    Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
    Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
    J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
    Chauvet-Gélinier JC
    Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
    Keers R; Uher R; Gupta B; Rietschel M; Schulze TG; Hauser J; Skibinska M; Henigsberg N; Kalember P; Maier W; Zobel A; Mors O; Kristensen AS; Kozel D; Giovannini C; Mendlewicz J; Kumar S; McGuffin P; Farmer AE; Aitchison KJ
    J Affect Disord; 2010 Dec; 127(1-3):337-42. PubMed ID: 20609482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
    Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
    Perroud N; Uher R; Marusic A; Rietschel M; Mors O; Henigsberg N; Hauser J; Maier W; Souery D; Placentino A; Szczepankiewicz A; Jorgensen L; Strohmaier J; Zobel A; Giovannini C; Elkin A; Gunasinghe C; Gray J; Campbell D; Gupta B; Farmer AE; McGuffin P; Aitchison KJ
    BMC Med; 2009 Oct; 7():60. PubMed ID: 19832967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depressive subtypes and treatment response.
    Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
    Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.
    Uher R; Maier W; Hauser J; Marusic A; Schmael C; Mors O; Henigsberg N; Souery D; Placentino A; Rietschel M; Zobel A; Dmitrzak-Weglarz M; Petrovic A; Jorgensen L; Kalember P; Giovannini C; Barreto M; Elkin A; Landau S; Farmer A; Aitchison KJ; McGuffin P
    Br J Psychiatry; 2009 Mar; 194(3):252-9. PubMed ID: 19252156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-report and clinician-rated measures of depression severity: can one replace the other?
    Uher R; Perlis RH; Placentino A; Dernovšek MZ; Henigsberg N; Mors O; Maier W; McGuffin P; Farmer A
    Depress Anxiety; 2012 Dec; 29(12):1043-9. PubMed ID: 22933451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
    McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
    Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
    Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melancholia with onset during treatment with SSRIs.
    Swartz CM; Guadagno G
    Ann Clin Psychiatry; 1998 Dec; 10(4):177-9. PubMed ID: 9988059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nortriptyline for treatment-resistant depression.
    Nierenberg AA; Papakostas GI; Petersen T; Kelly KE; Iacoviello BM; Worthington JJ; Tedlow J; Alpert JE; Fava M
    J Clin Psychiatry; 2003 Jan; 64(1):35-9. PubMed ID: 12590621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.